Literature DB >> 24595141

Toll-like receptor stimulation induces nondefensin protein expression and reverses antibiotic-induced gut defense impairment.

Ying-Ying Wu1, Ching-Mei Hsu, Pei-Hsuan Chen, Chang-Phone Fung, Lee-Wei Chen.   

Abstract

Prior antibiotic exposure is associated with increased mortality in Gram-negative bacteria-induced sepsis. However, how antibiotic-mediated changes of commensal bacteria promote the spread of enteric pathogenic bacteria in patients remains unclear. In this study, the effects of systemic antibiotic treatment with or without Toll-like receptor (TLR) stimulation on bacterium-killing activity, antibacterial protein expression in the intestinal mucosa, and bacterial translocation were examined in mice receiving antibiotics with or without oral supplementation of dead Escherichia coli or Staphylococcus aureus. We developed a systemic ampicillin, vancomycin, and metronidazole treatment protocol to simulate the clinical use of antibiotics. Antibiotic treatment decreased the total number of bacteria, including aerobic bacteria belonging to the family Enterobacteriaceae and the genus Enterococcus as well as organisms of the anaerobic genera Lactococcus and Bifidobacterium in the intestinal mucosa and lumen. Antibiotic treatment significantly decreased the bacterium-killing activity of the intestinal mucosa and the expression of non-defensin-family proteins, such as RegIIIβ, RegIIIγ, C-reactive protein-ductin, and RELMβ, but not the defensin-family proteins, and increased Klebsiella pneumoniae translocation. TLR stimulation after antibiotic treatment increased NF-κB DNA binding activity, nondefensin protein expression, and bacterium-killing activity in the intestinal mucosa and decreased K. pneumoniae translocation. Moreover, germfree mice showed a significant decrease in nondefensin proteins as well as intestinal defense against pathogen translocation. Since TLR stimulation induced NF-κB DNA binding activity, TLR4 expression, and mucosal bacterium-killing activity in germfree mice, we conclude that the commensal microflora is critical in maintaining intestinal nondefensin protein expression and the intestinal barrier. In turn, we suggest that TLR stimulation induces nondefensin protein expression and reverses antibiotic-induced gut defense impairment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24595141      PMCID: PMC3993438          DOI: 10.1128/IAI.01578-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  Toll-like receptors; their physiological role and signal transduction system.

Authors:  O Takeuchi; S Akira
Journal:  Int Immunopharmacol       Date:  2001-04       Impact factor: 4.932

2.  Impact of empiric antibiotic regimen on bowel colonization in neonates with suspected early onset sepsis.

Authors:  U Parm; T Metsvaht; E Sepp; M-L Ilmoja; H Pisarev; M Pauskar; I Lutsar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-06       Impact factor: 3.267

Review 3.  Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit.

Authors:  Lisa L Maragakis
Journal:  Crit Care Med       Date:  2010-08       Impact factor: 7.598

4.  Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis.

Authors:  Michael T Johnson; Richard Reichley; Joan Hoppe-Bauer; W Michael Dunne; Scott Micek; Marin Kollef
Journal:  Crit Care Med       Date:  2011-08       Impact factor: 7.598

5.  Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases.

Authors:  Jeremy Dupaul-Chicoine; Garabet Yeretssian; Karine Doiron; Kirk S B Bergstrom; Christian R McIntire; Philippe M LeBlanc; Charles Meunier; Claire Turbide; Philippe Gros; Nicole Beauchemin; Bruce A Vallance; Maya Saleh
Journal:  Immunity       Date:  2010-03-11       Impact factor: 31.745

Review 6.  Effect of antimicrobial agents on the ecological balance of human microflora.

Authors:  A Sullivan; C Edlund; C E Nord
Journal:  Lancet Infect Dis       Date:  2001-09       Impact factor: 25.071

7.  Insulin-like growth factor-1 levels contribute to the development of bacterial translocation in sepsis.

Authors:  Gary W Hunninghake; Kevin C Doerschug; Amanda B Nymon; Gregory A Schmidt; David K Meyerholz; Alix Ashare
Journal:  Am J Respir Crit Care Med       Date:  2010-04-22       Impact factor: 21.405

8.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.

Authors:  Karthikeyan K Kumarasamy; Mark A Toleman; Timothy R Walsh; Jay Bagaria; Fafhana Butt; Ravikumar Balakrishnan; Uma Chaudhary; Michel Doumith; Christian G Giske; Seema Irfan; Padma Krishnan; Anil V Kumar; Sunil Maharjan; Shazad Mushtaq; Tabassum Noorie; David L Paterson; Andrew Pearson; Claire Perry; Rachel Pike; Bhargavi Rao; Ujjwayini Ray; Jayanta B Sarma; Madhu Sharma; Elizabeth Sheridan; Mandayam A Thirunarayan; Jane Turton; Supriya Upadhyay; Marina Warner; William Welfare; David M Livermore; Neil Woodford
Journal:  Lancet Infect Dis       Date:  2010-08-10       Impact factor: 25.071

9.  Reversal of the effect of albumin on gut barrier function in burn by the inhibition of inducible isoform of nitric oxide synthase.

Authors:  Lee-Wei Chen; Jyh-Seng Wang; Bonnie Hwang; Jin-Shyr Chen; Ching-Mei Hsu
Journal:  Arch Surg       Date:  2003-11

10.  Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation.

Authors:  Dionysios A Antonopoulos; Susan M Huse; Hilary G Morrison; Thomas M Schmidt; Mitchell L Sogin; Vincent B Young
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

View more
  13 in total

Review 1.  Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease.

Authors:  M N Quraishi; W Shaheen; Y H Oo; T H Iqbal
Journal:  Clin Exp Immunol       Date:  2019-11-27       Impact factor: 4.330

Review 2.  Toll-like Receptors and Inflammatory Bowel Disease.

Authors:  Yue Lu; Xinrui Li; Shanshan Liu; Yifan Zhang; Dekai Zhang
Journal:  Front Immunol       Date:  2018-01-30       Impact factor: 7.561

3.  Dysbiosis Modulates Ocular Surface Inflammatory Response to Liposaccharide.

Authors:  Changjun Wang; Laura Schaefer; Fang Bian; Zhiyuan Yu; Stephen C Pflugfelder; Robert A Britton; Cintia S de Paiva
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-10-01       Impact factor: 4.799

4.  Aryl hydrocarbon receptor ligands enhance lung immunity through intestinal IKKβ pathways.

Authors:  Tzyy-Bin Tsay; Pei-Hsuan Chen; Lee-Wei Chen
Journal:  J Transl Med       Date:  2019-09-05       Impact factor: 5.531

5.  Oral Supplementation of Lead-Intolerant Intestinal Microbes Protects Against Lead (Pb) Toxicity in Mice.

Authors:  Qixiao Zhai; Dingwu Qu; Saisai Feng; Yaqi Yu; Leilei Yu; Fengwei Tian; Jianxin Zhao; Hao Zhang; Wei Chen
Journal:  Front Microbiol       Date:  2020-01-22       Impact factor: 5.640

6.  Maternal aryl hydrocarbon receptor activation protects newborns against necrotizing enterocolitis.

Authors:  Peng Lu; Chhinder P Sodhi; Yukihiro Yamaguchi; William B Fulton; Sanxia Wang; Qinjie Zhou; Hongpeng Jia; Mark L Kovler; Andres Gonzalez Salazar; Maame Sampah; Thomas Prindle; Peter Wipf; David J Hackam
Journal:  Nat Commun       Date:  2021-02-15       Impact factor: 14.919

7.  Gut Microbiota-Derived Propionate Regulates the Expression of Reg3 Mucosal Lectins and Ameliorates Experimental Colitis in Mice.

Authors:  Danica Bajic; Adrian Niemann; Anna-Katharina Hillmer; Raquel Mejias-Luque; Sena Bluemel; Melissa Docampo; Maja C Funk; Elena Tonin; Michael Boutros; Bernd Schnabl; Dirk H Busch; Tsuyoshi Miki; Roland M Schmid; Marcel R M van den Brink; Markus Gerhard; Christoph K Stein-Thoeringer
Journal:  J Crohns Colitis       Date:  2020-10-05       Impact factor: 9.071

8.  Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface.

Authors:  Jacqueline Montanaro; Aleksandra Inic-Kanada; Angela Ladurner; Elisabeth Stein; Sandra Belij; Nora Bintner; Simone Schlacher; Nadine Schuerer; Ulrike Beate Mayr; Werner Lubitz; Nikolaus Leisch; Talin Barisani-Asenbauer
Journal:  Drug Des Devel Ther       Date:  2015-07-21       Impact factor: 4.162

9.  Lactobacillus salivarius reverse antibiotic-induced lung defense impairment in a ventilator model.

Authors:  Tzyy-Bin Tsay; Ming-Chieh Yang; Wan-Hsuan Chang; Pei-Hsuan Chen; Lee-Wei Chen
Journal:  J Transl Med       Date:  2018-08-13       Impact factor: 5.531

10.  Fecal microbiota transplantation alleviated Alzheimer's disease-like pathogenesis in APP/PS1 transgenic mice.

Authors:  Jing Sun; Jingxuan Xu; Yi Ling; Fangyan Wang; Tianyu Gong; Changwei Yang; Shiqing Ye; Keyue Ye; Dianhui Wei; Ziqing Song; Danna Chen; Jiaming Liu
Journal:  Transl Psychiatry       Date:  2019-08-05       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.